A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) ...
News-Medical.Net on MSN
Diabetes drugs linked to slower frailty progression in older adults
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) ...
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors—such as ...
The outside advisors analyzed the results of the RELIEVE-HF pivotal trial, which randomized 508 patients to either receive ...
A genetic variant is likely putting some children suffering with myocarditis—inflammation of the heart muscle—at higher risk ...
MedPage Today on MSN
FDA Panel on Interatrial Shunt for Heart Failure: It's a Hard No
An FDA advisory panel gave a unanimous verdict for an interatrial shunt in heart failure: no way.
Drugs like gabapentin and pregabalin are known to cause fluid retention, leading to symptoms that doctors can confuse for ...
Guideline-recommended therapies for heart failure (HF) were found to be ineffective in patients with HF caused by Chagas ...
News Medical on MSN
Your Pain Meds’ Side Effects May Be Masquerading as Heart Failure
Matthew Growdon's study finds "prescription cascades" where drug side effects lead to unnecessary second prescriptions, ...
The FDA’s Circulatory System Devices Panel voted not to recommend approving use of an interatrial shunt to improve heart failure symptoms and prognosis.In a 0-15 vote, the committee determined risk ...
Lexicon Pharmaceuticals, Inc. currently offers three late-stage assets Zynquista, Inpefa & Pilavapadin. Learn more about LXRX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results